RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site such as personalized content. Please see our Privacy Policy for more information.

Regulatory Advice

| 01 August 2009

Question: My company is planning to apply for authorization under the repeat-use Mutual Recognition Procedure (MRP) in Europe of a product that was registered in the Reference Member State (RMS) before 26 July 2008. Does Article 7 of the EU Paediatric Regulation apply in our case?

© 2023 Regulatory Affairs Professionals Society.

Regulatory News

Story Thumbnail
DARWIN EU ‘ramping up quickly’ with more partners coming on board
- 23 March 2023
Read More
Story Thumbnail
Stakeholders offer input on educational materials for rare disease drug development
- 22 March 2023
Read More
Story Thumbnail
NCI official raises concerns about FDA’s cancer drug dose optimization guidance
- 21 March 2023
Read More

Discover more of what matters to you

No taxonomy

News »

Stakeholders want clarity from FDA on circumstances for delaying or limiting inspections

Euro Roundup: MHRA advances major overhaul of UK clinical trial regulation after positive feedback

Books »

Fundamentals of Medical Device Regulations, Fifth Edition

Risk Management Principles for Devices and Pharmaceuticals, Third Edition

Learning »

China Drug Registration and Reimbursement (On-Demand)

Sponsored Webcast: UK Drug and Device Approvals Post Brexit (on-demand)

Events »

Artificial Intelligence Summit

Combination Products Summit 2023